Jaswant Singh Khera
Directeur/Membre du Conseil chez WEP Group Holdings Ltd.
Profil
Jaswant Singh Khera has held director positions at WEP Group Holdings Ltd.
and WE Pharma Ltd.
His current job(s) include being a Director at WEP Group Holdings Ltd.
and WE Pharma Ltd.
Postes actifs de Jaswant Singh Khera
| Sociétés | Poste | Début |
|---|---|---|
WEP Group Holdings Ltd.
 WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Directeur/Membre du Conseil | 19/12/2017 |
WE Pharma Ltd.
 WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |
WE Pharma Ltd.
WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |